No definition available.
Mandibular prognathia AND surgery (LeFortI or BSSRO)
K11_MN_PROGN_AND_SURGRT
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
1648 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
187 |
4. Check minimum number of eventsNone |
187 |
5. Include endpointsNone |
187 |
6. Filter based on genotype QC (FinnGen only) |
187 |
Control definitions (FinnGen only)
- Control exclude
- K11_MN_PROGN_AND_SURGRT_INCLAVO
Extra metadata
- First used in FinnGen datafreeze
- DF7
Similar endpoints
↥List of similar endpoints to
Mandibular prognathia AND surgery (LeFortI or BSSRO)
based on the number of shared cases.
Similar with more cases:
- Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo
- Mandibular prognathia
- LeFortI or BSSRO operation
- Dentofacial anomalies [including malocclusion]
- Diseases of oral cavity, salivary glands and jaws
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1251 | 708 | 535 |
| Only index persons | 1235 | 701 | 534 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 28.06 | 27.97 | 28.18 |
| Only index persons | 28.04 | 27.92 | 28.20 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 187 | 120 | 67 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.03 |
| Median age at first event (years) | 32.56 | 32.46 | 32.75 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 165
- Matched controls
- 1651
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K07.11
ICD-10 Finland
Retrognathism (mandibular)(maxillary)
+∞
236.4
165
*
EEC05
NOMESCO Finland
Le Fort I osteotomy
1602.8
150.5
124
*
K07.14
ICD-10 Finland
Retrognaty, maxillary
412.3
101.0
92
5
EDC10
NOMESCO Finland
Sagittal osteotomy of ramus of mandible
268.7
100.3
94
8
SJD00
NOMESCO Finland
Removal or reattacment of arrow in fixed orthodontisk device
116.0
99.5
103
23
SBB10
NOMESCO Finland
Teeth copy
59.0
95.5
117
65
SJD20
NOMESCO Finland
Attachment of modifiable arrow of fixed orthodontisk device
115.9
90.0
93
18
SJD10
NOMESCO Finland
Attachment of arrow to fixed orthodontisk device
91.4
88.3
95
24
SJC10
NOMESCO Finland
Orthodontic bandage in one tooth
121.2
87.7
90
16
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
63.8
79.0
91
31
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
51.9
74.5
90
37
SJC50
NOMESCO Finland
Removal of orthodontisk device with at least 7 brackets
72.6
73.5
82
22
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
113.0
72.2
75
12
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
78.2
71.8
79
19
EB1MA
NOMESCO Finland
Cephalometry with X-ray
63.8
71.6
82
25
SJD30
NOMESCO Finland
Demanding attachment of arrow to fixed orthodontisk device
86.5
70.3
76
16
SJD40
NOMESCO Finland
Fixation of ready made palatinal or lingual arrow
81.2
62.3
68
14
SJC03
NOMESCO Finland
Positioning and fixed attachment of brackets, extensive
56.5
46.4
54
14
K07.13
ICD-10 Finland
Retrognaty, mandibular
52.7
45.8
54
15
K07.10
ICD-10 Finland
Asymmetry of jaw
95.7
44.9
48
7
SAA04
NOMESCO Finland
Special inverstigation of mouth
21.7
43.1
66
49
K07.24
ICD-10 Finland
Open bite
58.9
40.8
47
11
SJC01
NOMESCO Finland
Positioning and fixed attachment of single bracket (Bracket with fixed attachment)
38.2
40.3
51
19
SJC00
NOMESCO Finland
Bracket with fixed attachment
466.7
38.7
37
*
SJX20
NOMESCO Finland
Check-up visit for orthodontisk therapy
43.1
38.3
47
15
K07.1
ICD-10 Finland
Anomalies of jaw-cranial base relationship
236.5
37.5
37
*
SJC40
NOMESCO Finland
Removal of orthodontisk device with at most 6 brackets
38.2
34.2
43
15
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
21.8
34.1
51
33
SJB60
NOMESCO Finland
External device grinding and adaptation
48.8
31.9
38
10
SXC05
NOMESCO Finland
Other oral or dental procedure
13.3
29.2
54
58
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
8.5
27.7
70
132
SJC02
NOMESCO Finland
Positioning and fixed attachment of brackets
28.2
25.1
34
15
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
66.9
24.9
28
5
SJA04
NOMESCO Finland
Very demanding plan for orthodontic care
102.3
24.4
26
*
K07.18
ICD-10 Finland
Another anomaly in the relationship between jaw and skull base
146.3
24.3
25
*
SJA03
NOMESCO Finland
Demanding plan for orthodontic care
265.3
23.2
23
*
SJX21
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment
23.0
22.3
32
17
SJX11
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment, restricted
20.9
21.0
31
18
SJB10
NOMESCO Finland
Fitting of loose orthodontic device with user information, demanding
66.3
20.5
23
*
K07.01
ICD-10 Finland
Hyperplasia, hypoplasia mandibular
+∞
20.2
19
*
SAC03
NOMESCO Finland
Separate planning of oral and dental treatment, very demanding
119.5
20.1
21
*
SAA03
NOMESCO Finland
Extended examination of mouth
4.7
19.3
113
523
K07.60
ICD-10 Finland
Snapping jaw
11.4
18.3
35
38
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
11.1
18.1
35
39
SJA01
NOMESCO Finland
Estimation of need for orthodontic care
106.7
18.0
19
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.4
18.0
95
388
EBB10
NOMESCO Finland
Insertion of dental implant
39.8
17.1
21
6
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
13.2
16.0
28
25
SJA02
NOMESCO Finland
Plan for orthodontic care
+∞
15.9
15
*
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
7.3
15.9
40
69
SXC03
NOMESCO Finland
Other oral or dental procedure
62.7
15.1
17
*
K07.21
ICD-10 Finland
Anomalies of dental arch relationship
88.2
14.8
16
*
K07.03
ICD-10 Finland
Micrognatia (hypoplasia) of the upper jaw
+∞
14.8
14
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.8
14.7
105
524
Z3229
NOMESCO Finland
Other healthcare associate professional
8.0
13.8
32
48
K07.19
ICD-10 Finland
Anomalies in the relationship between jaw and skull base UNS
+∞
13.7
13
*
SAC02
NOMESCO Finland
Separate planning of oral and dental treatment, demanding
31.3
13.2
17
6
EB1WA
NOMESCO Finland
NA
75.9
12.8
14
*
ZXE20
NOMESCO Finland
More than three and less than five hours
5.3
12.7
41
96
SJD50
NOMESCO Finland
Production and attachment of palatinal or lingual arrow
32.7
11.9
15
5
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
11.8
11.7
21
20
K00.00
ICD-10 Finland
Hypodontia
22.0
11.4
16
8
SJX00
NOMESCO Finland
Reparation of orthodontiskt device by dentist
46.8
11.1
13
*
SJF01
NOMESCO Finland
Assessment of need for orthodontic treatment
19.5
11.0
16
9
EBA10
NOMESCO Finland
Surgical removal of tooth
3.8
10.0
47
157
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
5.6
9.9
29
60
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
6.0
9.8
27
52
ZXE30
NOMESCO Finland
More than five and less than seven hours
7.2
9.7
23
36
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
105.8
9.5
10
*
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
14.8
9.4
15
11
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
39.0
9.1
11
*
ZXA10
NOMESCO Finland
Bilateral
3.7
8.8
41
135
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
52.9
8.8
10
*
EBB15
NOMESCO Finland
Insertion of dental implant abutment
52.9
8.8
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
8.6
59
257
K07.23
ICD-10 Finland
Deep bite
8.6
8.6
18
23
K07.4
ICD-10 Finland
Malocclusion, unspecified
21.4
8.6
12
6
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
14.3
7.5
12
9
J01CE02
ATC
phenoxymethylpenicillin; oral
2.8
6.9
134
1006
K01.0
ICD-10 Finland
Embedded teeth
8.4
6.8
14
18
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
23.6
6.7
9
*
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
9.3
6.7
13
15
SJE90
NOMESCO Finland
Finishing face of orthodontick therapy
72.5
6.5
7
*
SDA02
NOMESCO Finland
Parodonthologic therapy
2.4
6.5
69
378
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
6.8
6.3
15
24
EEC02
NOMESCO Finland
Rapid expansion of maxilla
+∞
6.3
6
*
K01.17
ICD-10 Finland
Retained molar with obstruction in the lower jaw
7.2
6.2
14
21
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
7.7
6.1
13
18
M01AE03
ATC
ketoprofen; systemic, rectal
2.4
6.0
60
315
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3041096) Erythrocytes [Presence] in Urine by Automated
63
421
1.75
3.08
3.0
2.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
17
4.86
2.95
1.3
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
36
214
1.84
2.57
1.7
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
29
164
1.91
2.40
1.7
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
35
212
1.80
2.35
1.5
1.6
pmol/l
461.6
482.6
0.14
27
190
(40765089) Chromosome analysis panel - Blood by G-banded
6
13
4.73
2.29
1.0
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
41
270
1.66
2.05
1.6
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
26
3.17
2.04
2.0
1.6
%
13.1
13.4
—
8
26
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
74
563
1.52
2.01
3.3
2.9
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
6
17
3.61
1.85
2.8
2.1
mmol/l
6.6
6.6
—
6
17
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
88
706
1.47
1.80
4.0
4.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
92
746
1.46
1.77
3.2
3.0
estimate
0.0
0.0
0.00
12
132
(3044640) Blood type and Crossmatch panel - Blood
59
439
1.50
1.75
1.7
2.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
22
356
0.57
1.73
2.5
2.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
91
740
1.45
1.71
3.2
3.0
estimate
0.0
0.0
0.00
12
137
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
156
1412
1.63
1.71
3.6
3.6
mmol/l
5.6
5.7
0.83
145
1318
(3008037) Lactate [Moles/volume] in Venous blood
6
19
3.23
1.67
2.8
1.9
mmol/l
1.3
1.2
—
6
19
(3021601) Nitrite [Presence] in Urine by Test strip
90
735
1.43
1.63
5.0
4.2
estimate
0.0
0.0
0.00
13
139
(1761868) Lipid panel - Serum or Plasma
78
622
1.44
1.61
2.7
2.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
60
763
0.69
1.60
4.0
5.4
e9/l
0.0
0.0
0.11
55
667
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
71
560
1.43
1.54
4.0
7.0
mmol/l
1.2
1.2
1.68
62
486
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
55
417
1.45
1.46
2.1
2.4
u/l
52.3
54.8
0.37
55
393
(40761511) CBC panel - Blood by Automated count
176
1661
2.01
1.46
10.5
9.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
23
2.66
1.38
6.8
2.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
131
1165
1.42
1.36
4.1
4.1
pmol/l
14.6
14.5
0.22
120
1086
(40768793) Breast Pathology biopsy report
0
40
0.00
1.34
0.0
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
8
36
2.28
1.26
2.3
1.5
u/l
10.5
21.6
—
8
31
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
19
2.67
1.22
1.0
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
118
1041
1.36
1.22
3.8
3.8
—
—
—
0
0
(3015736) pH of Urine
72
589
1.36
1.21
2.8
2.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
55
431
1.39
1.20
2.2
2.6
ng/l
86.3
35.3
0.35
24
219
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
57
450
1.38
1.19
1.7
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
144
1314
1.42
1.19
4.8
4.4
mmol/mol
37.9
38.4
0.39
135
1256
(3019150) Specific gravity of Urine by Refractometry
44
336
1.40
1.11
2.7
3.1
kg/l
1.0
1.0
—
9
41
(3018095) Leukocytes [#/volume] in Urine
36
474
0.70
1.10
3.0
3.2
e6/l
54.6
43.9
0.14
25
308
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
43
330
1.39
1.06
1.5
2.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
155
1445
1.42
1.02
10.5
13.2
g/l
335.1
333.7
1.34
155
1439
(3002582) Erythrocytes [#/volume] in Urine
29
389
0.70
0.98
2.8
2.7
e6/l
42.9
41.0
0.03
24
293
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
45
353
1.36
0.97
2.4
2.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
31
0.00
0.97
0.0
1.5
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
5
102
0.48
0.92
3.8
13.3
%
98.4
96.8
—
5
97
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
49
394
1.33
0.90
2.2
2.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
120
1089
1.28
0.87
3.1
3.7
mm/h
7.9
8.8
0.51
115
1009
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
6
111
0.53
0.86
2.7
2.8
g/l
0.2
0.2
—
6
104
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
148
1382
1.34
0.86
4.6
4.7
mu/l
1.7
1.8
0.41
137
1303
(3030467) Casts [#/volume] in Urine by Automated count
26
347
0.71
0.85
2.9
2.7
e6/l
0.9
0.3
0.42
21
255
(3032080) INR in Blood by Coagulation assay
52
427
1.30
0.83
5.9
5.1
inr
1.0
1.1
0.30
22
129
(40758558) Short blood count panel - Blood
27
355
0.72
0.81
2.3
6.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
5
97
0.50
0.80
3.8
13.9
g/l
128.8
123.8
—
5
91
(4035726)
5
98
0.50
0.80
2.2
1.3
—
—
—
0
0
(4034850)
8
48
1.70
0.80
8.1
8.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
89
786
1.25
0.78
3.3
4.6
mmol/l
6.3
6.4
0.34
79
701
(3015377) Calcium [Moles/volume] in Serum or Plasma
32
407
0.74
0.78
1.5
2.9
mmol/l
2.4
2.4
0.38
27
365
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
10
160
0.60
0.78
2.7
2.3
ug/l
0.5
0.7
—
5
83
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
29
220
1.38
0.77
2.2
2.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
171
1642
1.48
0.75
6.9
8.9
u/l
25.8
27.3
0.62
166
1598
(3022621) pH of Urine by Test strip
13
84
1.59
0.74
2.7
2.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
23
169
1.41
0.74
1.2
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
160
1524
1.35
0.69
3.9
3.9
mmol/l
2.8
2.9
0.36
153
1434
(42870588) Differential panel, method unspecified - Blood
39
474
0.78
0.69
4.0
5.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
43
1.65
0.67
1.0
1.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
78
874
0.82
0.67
5.7
8.9
e9/l
3.9
3.9
0.01
73
757
(3009542) Hematocrit [Volume Fraction] of Blood
160
1527
1.33
0.66
9.4
11.3
%
40.8
41.0
0.16
124
1276
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
14
197
0.69
0.63
2.9
2.5
e6/l
3.6
3.4
—
6
103
(40761536) Microorganisms panel - Urine sediment
17
122
1.43
0.62
3.2
3.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
57
656
0.81
0.62
9.0
7.4
e9/l
0.0
0.0
0.00
50
520
(3019225) pH of Specimen
15
105
1.47
0.62
1.4
4.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
102
932
1.21
0.60
2.6
3.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
60
522
1.22
0.58
1.8
1.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
36
433
0.79
0.58
2.6
2.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
152
1448
1.27
0.58
3.3
3.3
mmol/l
1.2
1.3
0.26
146
1363
(3011397) Hemoglobin [Presence] in Urine by Test strip
28
347
0.77
0.57
2.9
3.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
163
1567
1.31
0.56
9.5
10.5
mg/l
20.0
19.5
0.07
130
1168
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
157
1503
1.28
0.56
3.6
3.6
mmol/l
1.5
1.5
0.11
150
1418
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
100
1.43
0.53
1.3
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
16
118
1.39
0.52
1.3
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
38
319
1.24
0.51
1.4
1.7
mg/l
0.7
0.8
0.36
29
235
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
65
1.40
0.51
1.4
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
24
191
1.29
0.49
2.1
1.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
32
382
0.80
0.49
1.6
1.4
g/l
1.9
2.2
0.42
23
240
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
16
120
1.36
0.48
2.6
2.4
u/l
465.7
5993.0
—
5
54
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
41
352
1.21
0.45
1.7
1.5
—
—
—
0
0
(3013512) EKG study
36
305
1.22
0.45
3.4
2.9
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
25
203
1.27
0.45
1.6
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
26
213
1.26
0.44
1.6
3.4
ng/l
9.5
215.8
1.41
15
136
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
10
70
1.45
0.42
1.4
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
13.6
—
834.8
—
0
17
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
19.8
—
1663.2
—
0
17
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
17
0.00
0.41
0.0
1.9
—
721.4
—
0
5
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
136
1418
0.85
0.40
7.6
9.0
ml/min/173m2
93.8
92.2
0.35
109
1115
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
34
1.48
0.40
1.2
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
34
1.48
0.40
1.2
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
34
1.48
0.40
2.0
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
18
142
1.30
0.40
2.3
1.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
140
1341
1.18
0.39
4.0
3.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
9
66
1.38
0.39
1.2
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
114
0.69
0.38
1.3
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
17
212
0.78
0.38
2.5
2.4
e6/l
1.4
0.9
—
8
118
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
69
1.32
0.38
1.4
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
32
274
1.20
0.37
1.3
1.3
u/ml
2.0
5.6
1.13
16
118
(3000492) Spirometry study
19
153
1.27
0.37
1.4
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
156
1511
1.20
0.36
3.8
3.7
mmol/l
4.7
4.7
0.09
148
1427
(3000494) Fungus identified in Specimen by Culture
20
163
1.25
0.36
1.2
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
77
711
1.14
0.35
2.7
2.7
ug/l
81.6
95.7
0.41
71
667
(40760892) CBC W Ordered Manual Differential panel - Blood
34
390
0.84
0.35
3.9
4.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
43
1.41
0.35
2.5
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
16
127
1.28
0.35
1.4
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
16
127
1.28
0.35
1.4
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
127
1.28
0.35
1.4
1.6
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
6
44
1.38
0.35
5.0
2.1
%
35.7
49.8
—
6
44
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
6
45
1.34
0.34
1.0
1.6
%
95.5
93.4
—
6
45
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
6
45
1.34
0.34
4.5
15.5
%
1.5
1.6
—
6
40
(3028300) Cannabinoids [Presence] in Urine
16
128
1.27
0.33
1.4
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
30
259
1.19
0.32
1.4
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
12
153
0.77
0.32
1.1
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
99
0.70
0.31
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
99
0.70
0.31
1.4
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
7
53
1.33
0.31
7.7
2.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
63
1.28
0.28
1.0
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
42
378
1.14
0.28
2.9
3.2
estimate
0.0
0.0
0.50
12
137
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
96
1.27
0.25
2.0
2.0
—
—
—
0
0
(4010399)
11
87
1.28
0.25
2.1
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
43
470
0.89
0.24
1.7
1.7
pmol/l
113.9
97.1
1.29
25
236
(40768804) Tissue Pathology biopsy report
53
572
0.90
0.24
2.0
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
91
0.76
0.23
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
28
313
0.88
0.22
3.0
3.5
mg/l
2927.7
313.6
0.41
17
201
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
102
0.77
0.21
1.6
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.4
—
910.1
—
0
10
(1617658) Protocol used for examination of sentinel lymph nodes
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
10
0.00
0.21
0.0
1.2
—
7.7
—
0
10
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
1.0
—
0
10
(3051651) Icteric interference index of Serum or Plasma
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
17
145
1.19
0.21
2.4
1.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
12
0.00
0.21
0.0
6.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
12
0.00
0.21
0.0
3.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
12
0.00
0.21
0.0
3.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(4281824)
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
43
1.17
0.21
1.2
2.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
13
108
1.22
0.20
1.2
2.2
e9/l
4.2
4.0
0.12
13
96
(3002523) Influenza virus A Ag [Presence] in Specimen
6
48
1.26
0.20
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
48
1.26
0.20
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
0
14
0.00
0.20
0.0
1.6
—
0.1
—
0
9
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
4.5
—
85.8
—
0
14
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
0
14
0.00
0.20
0.0
1.7
—
617.6
—
0
9
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
53
1.14
0.19
2.3
2.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
48
514
0.91
0.18
4.1
4.5
g/l
37.0
37.5
0.30
43
490
(3002256) Pathology report gross observation
14
163
0.85
0.18
1.1
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
69
1.17
0.16
1.5
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
8
69
1.17
0.16
1.8
1.3
u/l
7.4
9.8
—
8
60
(3020682) Albumin/Creatinine [Ratio] in Urine
30
327
0.90
0.16
4.3
4.0
mg/mmol
1.2
13.1
2.70
18
209
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
78
0.76
0.16
1.5
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
83
1.22
0.16
2.0
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
83
1.22
0.16
1.5
2.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
18
159
1.15
0.15
1.2
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
51
540
0.92
0.15
2.6
2.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
35
377
0.91
0.15
3.4
2.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
88
0.79
0.15
1.4
1.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
7
88
0.79
0.15
1.4
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
29
270
1.09
0.11
1.5
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
115
0.86
0.11
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
115
0.86
0.11
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
115
0.86
0.11
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
115
0.86
0.11
1.4
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
30
281
1.08
0.10
1.3
1.3
iu/ml
10.2
28.1
1.97
14
82
(3025941) Bacteria identified in Stool by Culture
12
106
1.14
0.10
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
46
1.09
0.09
1.0
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
17
155
1.11
0.09
2.0
1.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
48
1.04
0.09
1.6
2.1
%
0.8
1.6
—
5
48
(3004588) Protein electrophoresis panel - Serum or Plasma
6
54
1.11
0.09
2.5
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
107
1.13
0.08
1.1
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
13
144
0.90
0.08
2.8
5.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
37
352
1.06
0.08
2.3
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
58
1.04
0.08
1.3
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
61
0.81
0.08
1.8
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
60
0.83
0.08
1.6
1.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
5
63
0.79
0.08
4.0
14.9
mmol/l
24.1
24.4
—
5
58
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
64
0.78
0.08
2.2
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
24
225
1.08
0.08
1.9
2.8
ng/l
502.5
489.5
0.02
19
190
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
176
1.09
0.08
1.5
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
9
83
1.09
0.07
2.2
3.7
ng/l
68.1
69.2
—
9
76
(3042936) Bacteria identified in Isolate by Culture
17
183
0.92
0.07
1.9
2.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
20
213
0.93
0.06
3.7
3.3
%
20.6
22.9
—
8
75
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
41
424
0.96
0.05
1.3
1.3
u/ml
0.7
1.2
1.00
11
118
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
52
506
1.04
0.05
3.1
6.0
mmol/l
1.2
1.2
0.96
44
463
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
44
427
1.04
0.05
1.9
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
13
140
0.92
0.04
1.6
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
11
102
1.08
0.03
1.2
1.3
—
30.3
—
0
8
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
10
108
0.92
0.03
1.7
4.0
pmol/l
4.6
4.8
—
10
94
(3017181) Myelocytes/100 leukocytes in Blood
10
104
0.96
0.00
4.4
5.1
%
0.0
0.8
—
5
29
(3001019) Free T4 and TSH panel - Serum or Plasma
11
114
0.96
0.00
1.0
1.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
12
116
1.04
0.00
2.8
4.2
u/l
199.2
236.6
2.00
12
111
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
38
376
1.01
0.00
1.8
1.7
mmol/l
1.6
1.4
0.47
33
335
(3023368) Bacteria identified in Blood by Culture
28
279
1.00
0.00
5.1
4.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
97
1.03
0.00
1.2
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
11
107
1.03
0.00
3.2
2.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
13
127
1.03
0.00
1.5
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
158
1.01
0.00
1.3
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
95
1.06
0.00
1.7
1.5
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
12.5
—
0
8
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
6
66
0.91
0.00
3.3
11.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.0
—
5.5
—
0
8
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3012544) pH of Venous blood
9
96
0.93
0.00
2.6
3.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
22
220
1.00
0.00
1.4
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
12.7
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.7
—
82.8
—
0
6
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.7
—
2.0
—
0
6
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
17.4
—
0
6
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
5
0.00
0.00
0.0
2.6
—
10.8
—
0
5
(3028308) Erythrocytes [#/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
12.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
9.7
—
0
6
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
24.9
—
0
6
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
6
62
0.97
0.00
2.5
1.6
nmol/l
28.0
37.6
—
6
62
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
112.3
—
0
9
(3035320) C reactive protein [Mass/volume] in Body fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
1658.7
—
0
7
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.3
—
108.3
—
0
7
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
5.8
—
0
5
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
54
0.92
0.00
2.0
5.9
mmol/l
25.2
24.9
—
5
54
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
6
69
0.87
0.00
1.5
2.1
u/l
39.2
39.6
—
6
63
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
8.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint K11_MN_PROGN_AND_SURGRT and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have K11_MN_PROGN_AND_SURGRT.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: K11_MN_PROGN_AND_SURGRT – Mandibular prognathia AND surgery (LeFortI or BSSRO)
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data